Skip to content

Treating nightmares and insomnia in posttraumatic stress disorder: a review of current evidence.

Carla M Nappi, Sean P A Drummond, Joshua M H Hall

Neuropharmacology March 17, 2011 DOI: 10.1016/j.neuropharm.2011.02.029 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Topics Dreaming PTSD
Keywords Humans Hypnotics and sedatives Antipsychotic agents Antidepressive agents Treatment outcome Dreams Stress disorders, post-traumatic Behavior therapy
Key findings Argues that some behavioral and pharmacological interventions show promise for posttraumatic nightmares and insomnia, especially nightmares, but that controlled trials with valid sleep measures and designs capable of identifying treatment mechanisms are needed. Proposes that combining or sequencing behavioral and pharmacological treatments targeting both daytime and nighttime PTSD symptoms may improve outcomes over treating sleep symptoms in isolation.

Abstract

Emerging evidence supports the notion of disrupted sleep as a core component of Posttraumatic Stress Disorder (PTSD). Effective treatments for nighttime PTSD symptoms are critical because sleep disruption may be mechanistically linked to development and maintenance of PTSD and is associated with significant distress, functional impairment, and poor health. This review aimed to describe the state of science with respect to the impact of the latest behavioral and pharmacological interventions on posttraumatic nightmares and insomnia. Published studies that examined evidence for therapeutic effects upon sleep were included. Some behavioral and pharmacological interventions show promise, especially for nightmares, but there is a need for controlled trials that include valid sleep measures and are designed to identify treatment mechanisms. Our ability to treat PTSD-related sleep disturbances may be improved by moving away from considering sleep symptoms in isolation and instead conducting integrative studies that examine sequential or combined behavioral and/or pharmacological treatments targeting both the daytime and nighttime aspects of PTSD. This article is part of a Special Issue entitled 'Post-Traumatic Stress Disorder'.

Comparable studies

Other narrative reviews on PTSD, most cited first.

Citations in the library

Cited by 15

and 10 more in the library

Cites 13

and 8 more in the library

Explore topics